Evidence map›Paper›PMID 37234712›Full record

ArticleFrontiers in pharmacology2023

Pratap G Kenchappa, Yalpi Karthik, Poornima D Vijendra, Raghavendra L S Hallur, Ajay S Khandagale, Ashok K Pandurangan, Sathisha G Jayanna, Mohammed Ali Alshehri, Abdulrahman Alasmari, Samy Sayed and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Pharmacological Characterization ofRecent advances in inflammation & allergy drug discovery · 2026
    Article
  2. Mechanistic Insights into the Neuroprotective Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pratap G KenchappaDepartment of Studies and Research in Biochemistry, Jnana Kaveri Post Graduate Centre, Mangalore University, Kodagu, Karnataka, India.
Yalpi KarthikDepartment of Studies and Research in Microbiology, Jnana Kaveri Campus, Mangalore University, Kodagu, Karnataka, India.
Poornima D VijendraDepartment of Studies in Food Technology, Davangere University, Davangere, Karnataka, India.
Raghavendra L S HallurCenter for Biotechnology, Pravara Institute of Medical Sciences (Deemed to Be University), Ahmednagar, Maharashtra, India.
Ajay S KhandagaleSDM Research Institute for Biomedical Sciences (SDMRIBS) Shree Dharmasthala Manjunatheshwara University, Dharwad, Karnataka, India.
Ashok K PanduranganSchool of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, India.
Sathisha G JayannaDepartment of Biochemistry, Jnanasahyadri, Kuvempu University, Shivamogga, Karnataka, India.
Mohammed Ali AlshehriDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
Abdulrahman AlasmariDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
Samy SayedDepartment of Science and Technology, University College-Ranyah, Taif University, Taif, Saudi Arabia.
Manjula ShantaramDepartment of Studies and Research in Biochemistry, Jnana Kaveri Post Graduate Centre, Mangalore University, Kodagu, Karnataka, India.
Muntazir MushtaqMS Swaminathan School of Agriculture, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a type of neurodegenerative disease, associated with the hastening of ROS, acetylcholinesterase (AChE) activity, and amyloid β peptides plaques in the brain. The limitations and side effects of existing synthetic drugs incline toward natural sources. In the present communication active principles of methanolic extract of

Indexed as

acetylcholinesterasealzeheimer’s diseaseamyloidbetaGC-LCMSolea dioica roxbSHSY-5Y

Identifiers

PMID37234712
PMCPMC10205999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.